These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3897582)

  • 21. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
    Pak CY; Fuller C
    Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gouty diathesis and sarcoidosis in patient with recurrent calcium nephrolithiasis.
    Harvey JA; Pak CY
    J Urol; 1988 Jun; 139(6):1287-9. PubMed ID: 3373603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia.
    Whalley NA; Meyers AM; Martins M; Margolius LP
    Br J Urol; 1996 Jul; 78(1):10-4. PubMed ID: 8795392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
    Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM
    J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
    Trinchieri A; Esposito N; Castelnuovo C
    Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients.
    Cicerello E; Merlo F; Gambaro G; Maccatrozzo L; Fandella A; Baggio B; Anselmo G
    J Urol; 1994 Jan; 151(1):5-9. PubMed ID: 8254832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of orange juice consumption on urinary stone risk factors.
    Wabner CL; Pak CY
    J Urol; 1993 Jun; 149(6):1405-8. PubMed ID: 8501777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
    MCINTOSH HW; SERAGLIA M
    Can Med Assoc J; 1963 Dec; 89(24):1242-3. PubMed ID: 14084708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
    Ettinger B; Pak CY; Citron JT; Thomas C; Adams-Huet B; Vangessel A
    J Urol; 1997 Dec; 158(6):2069-73. PubMed ID: 9366314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Citrate (CG-120) therapy for urolithiasis. 1. Clinical effects].
    Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
    Hinyokika Kiyo; 1988 May; 34(5):905-17. PubMed ID: 3051945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
    Preminger GM; Sakhaee K; Pak CY
    J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A COMPARISON BETWEEN TWO POTASSIUM CITRATE REGIMENS FOR THE TREATMENT OF NEPHROLITHIASIS].
    Drori T; Abu-Ghanem Y; Kleinmann N; Shvero A; Winkler HZ; Zilberman DE
    Harefuah; 2019 Dec; 158(12):774-777. PubMed ID: 31823528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy.
    Lojanapiwat B; Tanthanuch M; Pripathanont C; Ratchanon S; Srinualnad S; Taweemonkongsap T; Kanyok S; Lammongkolkul S
    Int Braz J Urol; 2011; 37(5):611-6. PubMed ID: 22099273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracorporeal shock wave lithotripsy of impacted radiolucent stone at the right pyeloureteric junction and oral dissolution therapy in a patient with transplanted liver: a case report.
    Mokos I; Pasini J; Hrstić I; Stern-Padovan R; Cacic Z; Knezevic N
    Transplant Proc; 2007 Dec; 39(10):3533-5. PubMed ID: 18089430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent nephrolithiasis: natural history and effect of phosphate therapy. A double-blind controlled study.
    Ettinger B
    Am J Med; 1976 Aug; 61(2):200-6. PubMed ID: 782240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.